These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9889211

  • 21. [Candida dubliniensis studies and isolation of Candida types in oropharyngeal specimens from oncologic patients].
    Tekeli A, Dolapçi I, Cesur S, Tekeli E, Içli F.
    Mikrobiyol Bul; 2002 Jan; 36(1):57-63. PubMed ID: 12476767
    [Abstract] [Full Text] [Related]

  • 22. Carbohydrate assimilation profiles of the first Italian Candida dubliniensis clinical isolates recovered from an HIV-infected individual.
    Giammanco GM, Pignato S, Salvo S, Giammanco G.
    Res Microbiol; 2000 Dec; 151(10):889-91. PubMed ID: 11191815
    [Abstract] [Full Text] [Related]

  • 23. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrasekhar MR, Patil BS.
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [Abstract] [Full Text] [Related]

  • 24. Rapid identification of Candida dubliniensis with commercial yeast identification systems.
    Pincus DH, Coleman DC, Pruitt WR, Padhye AA, Salkin IF, Geimer M, Bassel A, Sullivan DJ, Clarke M, Hearn V.
    J Clin Microbiol; 1999 Nov; 37(11):3533-9. PubMed ID: 10523548
    [Abstract] [Full Text] [Related]

  • 25. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
    Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003
    [Abstract] [Full Text] [Related]

  • 26. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR.
    Indian J Pathol Microbiol; 2009 Mar; 52(4):501-4. PubMed ID: 19805956
    [Abstract] [Full Text] [Related]

  • 27. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A, HIV Epidemiology Research Study (HERS) Group.
    J Infect Dis; 2001 Jan 15; 183(2):286-93. PubMed ID: 11204125
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Adherence of different Candida dubliniensis isolates in the presence of fluconazole.
    Borg-von Zepelin M, Niederhaus T, Gross U, Seibold M, Monod M, Tintelnot K.
    AIDS; 2002 Jun 14; 16(9):1237-44. PubMed ID: 12045488
    [Abstract] [Full Text] [Related]

  • 33. Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods.
    Alvarez MI, Suárez BL, Caicedo LD.
    Mycopathologia; 2009 Jan 14; 167(1):19-24. PubMed ID: 18622716
    [Abstract] [Full Text] [Related]

  • 34. Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
    Castro LÁ, Álvarez MI, Martínez E.
    Mycopathologia; 2013 Feb 14; 175(1-2):91-8. PubMed ID: 23086383
    [Abstract] [Full Text] [Related]

  • 35. Discrimination between Candida albicans and Candida dubliniensis isolated from HIV-positive patients by using commercial method in comparison with PCR assay.
    Bujdáková H, Melkusová S, Soji I, Mokrás M, Mikami Y.
    Folia Microbiol (Praha); 2004 Feb 14; 49(4):484-90. PubMed ID: 15530017
    [Abstract] [Full Text] [Related]

  • 36. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
    Lasker BA, Elie CM, Lott TJ, Espinel-Ingroff A, Gallagher L, Kuykendall RJ, Kellum ME, Pruitt WR, Warnock DW, Rimland D, McNeil MM, Reiss E.
    Med Mycol; 2001 Aug 14; 39(4):341-52. PubMed ID: 11556764
    [Abstract] [Full Text] [Related]

  • 37. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systems.
    Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, Soll DR.
    J Clin Microbiol; 1999 Dec 14; 37(12):3804-8. PubMed ID: 10565888
    [Abstract] [Full Text] [Related]

  • 38. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 14; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Oral colonization by yeasts in HIV-positive patients in Brazil.
    Junqueira JC, Vilela SF, Rossoni RD, Barbosa JO, Costa AC, Rasteiro VM, Suleiman JM, Jorge AO.
    Rev Inst Med Trop Sao Paulo; 2012 Oct 14; 54(1):17-24. PubMed ID: 22370749
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.